HLA-C and neoplasm: Upon TCR recognition of tumor-associated antigens displayed on class I or class II MHC molecules of antigen-presenting cells (APCs), T cells activate, expand, differentiate, and infiltrate the cancer site to eliminate tumor cells [98].